Analytical and clinical performance of NT-proBNP immunoassay.

被引：0
|
作者：
Zucchelli, G [1 ]
Prontera, C [1 ]
Ripoli, A [1 ]
Emdin, M [1 ]
Iervasi, A [1 ]
Passino, C [1 ]
Mercuri, A [1 ]
Clerico, A [1 ]
机构：
[1] CNR, Ist Fisiol Clin, I-56100 Pisa, Italy
来源：
CLINICAL CHEMISTRY | 2003年 / 49卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A37 / A37
页数：1
相关论文
共 50 条
  • [31] Evaluation of a New NT-proBNP Immunoassay on an Automated Core Laboratory System
    Logan, Samantha
    Di Meo, Ashley
    Shapero, Stacey
    Fabros, Anselmo
    Taher, Jennifer
    Kulasingam, Vathany
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2024, 9 (03): : 579 - 585
  • [32] Cross-reactivity studies of BNP, proBNP, and NT-proBNP in commercial NT-proBNP assays
    Apple, F. S.
    Luckenbill, K. N.
    Jaffe, A. S.
    Mair, J.
    Ordonez-Llanos, J.
    Wu, A. H.
    Pagani, F.
    Tate, J.
    Saenger, A.
    Christenson, R. H.
    Ler, R.
    Murakami, M. M.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A84 - A84
  • [33] Analytical and clinical performance of the NT-proBNP assay on the Dade Behring Dimension® clinical chemistry system and the Stratus® CSSTAT Fluorometric Analyzer
    Christenson, RH
    Scott, MG
    Hock, KG
    Jones, HL
    Figgs, TR
    CLINICAL CHEMISTRY, 2005, 51 : A19 - A20
  • [34] Preliminary crossreactivity studies of proBNP, BNP and NT-proBNP in commercial BNP and NT-proBNP assays
    Apple, F. S.
    Luckenbill, K.
    Ler, R.
    Murakami, M. M.
    Christenson, R.
    Jaffe, A.
    Mair, J.
    Ordonez-Llanoss, J.
    Pagani, F.
    Tate, J.
    Wu, A.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A6 - A7
  • [35] Clinical value of NT-ProBNP and BNP in pediatric cardiology
    Nir, A
    Nasser, N
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (05) : S76 - S80
  • [36] Barostim, NT-proBNP, And Clinical Outcomes In Heart Failure
    Abraham, Joseph d.
    Abraham, William t.
    Lindenfeld, Joann
    Weaver, Fred a.
    Zannad, Faiez
    Wilks, Seth
    Rogers, Tyson
    Zile, Michael r.
    JOURNAL OF CARDIAC FAILURE, 2025, 31 (01)
  • [37] Clinical levels for enhanced assessment of NT-proBNP (CLEAN)
    Zions, M.
    Alam, M. E.
    Bernstein, L. H.
    Haq, S. A.
    Seamonds, B.
    Berger, S.
    Zarich, S.
    Conklin, K.
    Heitner, J.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A16 - A16
  • [38] Clinical utility of the cardiac markers BNP and NT-proBNP
    Buchner, S
    Riegger, G
    Luchner, A
    ACTA MEDICA AUSTRIACA, 2004, 31 (04) : 144 - 151
  • [39] The impact of introducing an NT-proBNP service into clinical practice
    Knowles, S
    Burn, S
    Cassidy, M
    Wood, P
    Mayne, J
    Docherty, D
    Harrop, JS
    CLINICA CHIMICA ACTA, 2005, 355 : S110 - S110
  • [40] Inflammation results in increased levels of NT-proBNP and an increased NT-proBNP/BNP ratio
    Jensen, J.
    Ma, L. P.
    Fu, M.
    Hammarsten, O.
    EUROPEAN HEART JOURNAL, 2010, 31 : 281 - 281
12345